
Transchem (TRANSCHEM) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
24.2M
Gross Profit
-1.9M
-8.01%
Operating Income
-4.8M
-19.94%
Net Income
7.3M
30.10%
Balance Sheet Metrics
Total Assets
797.3M
Total Liabilities
4.1M
Shareholders Equity
793.2M
Debt to Equity
0.01
Cash Flow Metrics
Revenue & Profitability Trend
Transchem Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 26.3M | 4.1M | 0 | 0 | 0 |
Cost of Goods Sold | 32.8M | 10.7M | 7.1M | 6.9M | 8.1M |
Gross Profit | -6.5M | -6.6M | -7.1M | -6.9M | -8.1M |
Gross Margin % | -24.7% | -162.1% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | 0 | 2.1M |
Selling, General & Administrative | - | 6.7M | 6.2M | 15.2M | 5.6M |
Other Operating Expenses | 8.2M | 1.4M | 1.8M | 1.7M | 2.8M |
Total Operating Expenses | 8.2M | 8.2M | 8.1M | 16.9M | 10.6M |
Operating Income | -14.7M | -17.2M | -17.4M | -25.6M | -20.1M |
Operating Margin % | -55.9% | -419.7% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | 73.7M | 40.5M | 54.5M | 43.5M |
Interest Expense | - | 0 | 3.0K | 1.0K | 13.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 70.6M | 56.5M | 25.0M | 39.1M | 247.7M |
Income Tax | 18.4M | 14.5M | 12.7M | 10.4M | 6.2M |
Effective Tax Rate % | 26.0% | 25.6% | 50.6% | 26.6% | 2.5% |
Net Income | 52.3M | 42.0M | 12.4M | 28.7M | 241.5M |
Net Margin % | 198.7% | 1,025.2% | 0.0% | 0.0% | 0.0% |
Key Metrics | |||||
EBITDA | -14.6M | 56.6M | 24.9M | 41.1M | 24.7M |
EPS (Basic) | - | ₹3.43 | ₹1.01 | ₹2.34 | ₹19.73 |
EPS (Diluted) | - | ₹3.43 | ₹1.01 | ₹2.34 | ₹19.73 |
Basic Shares Outstanding | - | 12240000 | 12240000 | 12240000 | 12240000 |
Diluted Shares Outstanding | - | 12240000 | 12240000 | 12240000 | 12240000 |
Income Statement Trend
Transchem Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 423.4M | 3.2M | 345.0M | 342.2M | 117.1M |
Short-term Investments | 1.0M | 15.6M | 8.6M | 6.8M | 15.1M |
Accounts Receivable | 27.1M | 4.1M | 0 | - | - |
Inventory | - | - | 0 | 1.5M | 678.0K |
Other Current Assets | 4.7M | 9.0K | 12.0K | 12.0K | 1.7M |
Total Current Assets | 776.4M | 673.3M | 579.0M | 579.0M | 546.3M |
Non-Current Assets | |||||
Property, Plant & Equipment | - | 0 | 0 | 1.0K | 1.0K |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | -1.0K | - | - |
Total Non-Current Assets | 20.8M | 89.9M | 83.2M | 89.1M | 87.9M |
Total Assets | 797.3M | 763.2M | 662.3M | 668.1M | 634.2M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.4M | - | - | - | - |
Short-term Debt | - | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 661.0K | 216.0K | 286.0K | 557.0K | 409.0K |
Total Current Liabilities | 3.0M | 4.8M | 898.0K | 2.8M | 2.6M |
Non-Current Liabilities | |||||
Long-term Debt | - | - | - | - | - |
Deferred Tax Liabilities | 516.0K | 58.0K | 0 | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 1.1M | 1.9M | 3.0M | 2.3M | 2.2M |
Total Liabilities | 4.1M | 6.7M | 3.8M | 5.1M | 4.8M |
Equity | |||||
Common Stock | 122.4M | 122.4M | 122.4M | 122.4M | 122.4M |
Retained Earnings | - | 424.6M | 326.6M | 331.1M | 297.5M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 793.2M | 756.5M | 658.4M | 663.0M | 629.4M |
Key Metrics | |||||
Total Debt | 0 | 0 | 0 | 0 | 0 |
Working Capital | 773.4M | 668.5M | 578.1M | 576.2M | 543.7M |
Balance Sheet Composition
Transchem Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 70.6M | 56.5M | 25.0M | 39.1M | 247.7M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 317.1M | -436.2M | -2.1M | 194.6M | -294.8M |
Operating Cash Flow | 387.7M | -379.8M | 22.8M | 233.5M | -47.1M |
Investing Activities | |||||
Capital Expenditures | 5.3M | -30.0K | 0 | 0 | 259.3M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | 0 | -209.8M | -89.2M | -115.4M |
Investment Sales | 54.9M | 51.0M | 200.2M | 95.0M | 86.7M |
Investing Cash Flow | 60.2M | 51.0M | -9.6M | 5.8M | 230.5M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |
Free Cash Flow | 360.0M | -393.1M | 12.2M | 219.1M | -278.0M |
Net Change in Cash | 447.9M | -328.8M | 13.2M | 239.4M | 183.5M |
Cash Flow Trend
Transchem Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
10.16
Price to Book
0.67
Price to Sales
9.37
Profitability Ratios
Profit Margin
53.20%
Operating Margin
-19.94%
Return on Equity
6.59%
Return on Assets
6.55%
Financial Health
Current Ratio
116.96
Debt to Equity
0.00
Per Share Data
EPS (TTM)
₹4.27
Book Value per Share
₹65.21
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
transchem | 531.2M | 10.16 | 0.67 | 6.59% | 53.20% | 0.00 |
Beml Land Assets | 8.9B | -234.67 | 795.40 | -125.56% | 0.00% | 779.28 |
Cupid Breweries | 5.3B | 131.04 | - | 29.53% | -87.29% | -4.02 |
Yash Trading | 613.6M | - | 9.02 | -70.97% | 0.00% | 0.00 |
Vr Woodart | 579.7M | - | - | 6.17% | 0.00% | -1.00 |
Tecil Chemicals | 510.5M | -105.65 | - | 2.12% | 0.00% | -0.69 |
Financial data is updated regularly. All figures are in the company's reporting currency.